Highlights

  • Pro Medicus signs a five-year AUD 44M agreement with Advanced Radiology Management.
  • Cloud-based Visage 7 platform to be deployed across the radiology group.
  • Transaction-based model offers potential for additional utilisation-driven revenue.

Pro Medicus Limited (ASX:PME) announced that its U.S. subsidiary, Visage Imaging, Inc., has entered a five-year contract valued at AUD 44M with Advanced Radiology Management, LLC. The agreement centres on the deployment of the Visage 7 Enterprise Imaging Platform, including the Visage 7 Viewer, across the radiology group’s operations.

Advanced Radiology Management is described as a private radiology reading group known for its focus on quality, innovation, and collaborative practice culture. Under the terms, Visage 7 will be implemented as a cloud-based solution, creating a unified enterprise imaging platform for diagnostic interpretation. The transactional licensing structure provides scope for usage-based revenue over the duration of the agreement.

Implementation Roadmap

Planning for the rollout will commence immediately. The implementation will follow Visage Imaging’s established cloud-based deployment framework. The company has targeted a Go-Live timeframe of late Q2 in the 2026 calendar year.

The cloud delivery model forms part of Visage’s broader CloudPACS strategy, which has been adopted by a growing number of radiology groups in North America. The platform is intended to enable consistent, centralised access to diagnostic imaging tools across provider networks.

Also Read -  Kinetiko Energy (ASX:KKO) Raises AUD 3.15M to Advance South African

Gas Projects Industry Context and Demand Pressures

In announcing the contract, Pro Medicus highlighted broader pressures within the radiology landscape, including workforce shortages in North America and internationally. The company noted that this shortage has increased workload demands and contributed to provider fatigue, with practices seeking tools that support more efficient interpretation of imaging studies.

According to Pro Medicus, private radiology groups such as Advanced Radiology Management recognise the efficiency benefits associated with the Visage 7 platform upon deployment. The company also stated that its sales pipeline spans multiple market segments, including the private radiology space.

Share Performance of PME

PME was trading 4.23% higher at AUD 259.36 per share as of 17 November 2025.